The First Data on International Multicenter Clinical Study RheoSTAT-CP0691 on the Efficacy and Safety of Rheosorbilact® Infusion in Therapy of Purulent Peritonitis. prmd 2022, 5 (1), 34-46. https://doi.org/10.31636/prmd.v5i1.5.